Lonicera japonica Thunb., possesses antiviral and hepatoprotective activities, and is widely used as a health food and in cosmetics. However, its major constituents, caffeoylquinic acid derivatives, and their anti-HBV activity were lacking systematic research. In this study, four novel caffeoylquinic acids, five simple caffeic acids and fourteen known caffeoylquinic acids are isolated and identified from L. japonica. Most caffeoylquinic acids inhibited HBsAg and HBeAg secretion, and HBV DNA replication. In particular, 100 mg ml À1 monocaffeoylquinic acid 9 inhibits HBsAg and HBeAg 
Introduction
The hepatitis B virus (HBV) is a major global health problem, due to its worldwide distribution and potential adverse consequences. Current therapeutic strategies for HBV, however, are far from satisfactory.
1 Traditional Chinese medicines, with multiple components and diverse activities, are important sources for novel anti-HBV drug discoveries. Caffeoylquinic acids, which exist widely in the plant kingdom, especially in Asteraceae, 2 Umbelliferae, 3 and Caprifoliaceae, 4 are a type of polyphenol compound formed by esterication and condensation of a molecule of quinic acid and a multimolecule caffeic acid. Caffeoylquinic acids and their derivatives are reported to possess anti-HBV activities.
5,6
Lonicera japonica Thunb. (Caprifoliaceae) is native to East Asia. In China, L. japonica is widely cultivated in Shandong and Henan Provinces. Jin Yin Hua, also known as Ren Dong, the ower buds of L. japonica, are famous in traditional Chinese medicine. 7 During the recent decades, they have been used for treating inuenza, cold, fever, and infections. 8 Moreover, they have also been used in indigenous beverages, such as tea, in Korea and China for many years. 9 Previous phytochemical investigations have been reported for different types of chemical constituents, including avonoids, caffeoylquinic acids, iridoids, saponins, and other compounds. [9] [10] [11] [12] Furthermore, caffeoylquinic acids are major constituents of L. japonica.
13,14
However, the caffeoylquinic acid derivatives form L. japonica and their anti-HBV activities are lacking in systematic research.
To clarify the anti-HBV activity of caffeoylquinic acids from the ower buds of L. japonica Thunb., as well as four new caffeoylquinic acids (1) (2) (3) (4) , together with ve simple caffeic acids (5) (6) (7) (8) 17) , and fourteen known caffeoylquinic acids (9) (10) (11) (12) (13) (14) (15) (16) (18) (19) (20) (21) (22) (23) are systematically isolated and identied ( Fig. 1 ). More importantly, most caffeoylquinic acids exhibit signicantly anti-HBV activity, especially caffeoylquinic acids (6, 7, (9) (10) (11) (12) 17) . Furthermore, compound 23 (tricaffeoylquinic acid) appear to promote HBsAg and HBeAg secretion, and HBV DNA replication. Finally, the detailed structure-activity relationships of caffeoylquinic acids will be discussed in this research.
Province, People's Republic of China. The plants were identied by Dr XB Zeng of Shenzhen People's Hospital and a voucher specimen (no. 20170930) was deposited at Center Lab of Longhua Branch, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, Shenzhen, China.
Extraction and isolation
The air-dried and powdered L. japonica ower buds (6.5 kg) were extracted three times with 75% ethanol (EtOH, 3 Â 50 L) under room temperature and concentrated by evaporation in vacuo. Then the EtOH extract (1.5 kg) was suspended in distilled water and successively partitioned three times with cyclohexane, ethyl acetate (EtOAc), and n-butyl alcohol, respectively. The EtOAc fraction (83 g) was separated by silica gel column chromatography (5 Â 45 cm, 100-200 mesh, 1800 g) eluted with a gradient of dichloromethane-methanol (CH 2 Cl 2 -MeOH, 100 : 1 / 1 : 0, v/v) to afford 20 fractions (fractions [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] by TLC plate analysis.
Fr. 4 (yellow colloidal, 2.9 g) was subjected to Sephadex LH-20 column chromatography (2.3 Â 75 cm) isocratic eluted with CH 2 Cl 2 -MeOH (80 : 20, v/v) to afford 6 subfractions (Fr. 4-1 to Fr. [4] [5] [6] . Next, compound 5 (50.0 mg) was obtained through recrystallization in methanol from Fr. 4-6. Fr 6 -DMSO) and 13 C NMR (100 MHz, d 6 -DMSO) spectrum information, see Table 1 . 
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Caffeic acid (8) . Pale yellow, amorphous powder; 72.52 (C-1), 38.89 (C-2), 67.68 (C-3), 69.45 (C-4), 67.75 (C-5), 39.10 (C-6), 173.61 (C-7), 52. 
Ester hydrolysates and HPLC analysis
Ester hydrolysates of compounds 1-4 were carried out according to the following method. In brief, compounds 1-4 (each 2.0 mg) were hydrolysed by reaction in 1 N NaOH (4 ml) and tetrahydrofuran (4 ml) at 0 C for 4 h. The reaction mixture was extracted by adjusting pH to 4.5. The extraction product was directly analysed by reversed-phase HPLC using a Diamonsil C 18 analytical column (5 mm, 4.6 Â 250 mm), which was eluted isocratically with 25% acetonitrile in water (containing 0.1% formic acid) at a ow rate of 1 ml min À1 . The temperature of the column oven was 25 C, and 20 ml was injected into the system each time. The UV spectra were collected at 327 nm. Peaks of the ester hydrolysate of compounds 1-4 were identied by comparing the retention times of authentic samples of 4-Ocaffeoylquinic acid methyl ester (compound 14, t R ¼ 10.411 min) aer simultaneous treatment under the same conditions.
Cytotoxic activity assay
The HepG 2 cells and HepG 2.2.15 cells were from the American Type Culture Collection (ATCC, Manassas, USA). All the cells were maintained in DMEM containing 10% FBS (foetal bovine serum, HyClone, Logan, UT) and cultured at 37 C (5% CO 2 , 95% relative humidity). The cytotoxicity assay was performed, according to the MTT method in 96-well microplates. Briey, 200 ml of adherent cells was seeded into each well of the 96-well cell culture plates and allowed to adhere for 24 hours before drug addiction with an initial density of 1.0 Â 10 5 cells per ml.
Each tumour cell line was exposed to the test compounds at concentrations of 100, 50, and 20 mg ml À1 (DMEM with 0.1% DMSO) for three times within 48 hours. The control group was treated in the same solvent. Aer 48 hours, the media and test samples were replaced with MTT (5 mg ml À1 ) and incubated in the dark for 4 h. The formazan crystals formed were dissolved in DMSO. Absorbance was measured using a microplate reader at 520 nm. Cell viability (%) was calculated as A sample /A control Â 100%.
Anti-HBV activity assay
HepG 2.2.15 cells were maintained in DMEM containing 10% FBS (foetal bovine serum, HyClone, Logan, UT) and cultured at 37 C (5% CO 2 , 95% relative humidity). The anti-HBV assay was performed according to previous research. 15 Briey, 500 ml of adherent cells was seeded into each well of the 24-well cell culture plates and allowed to adhere for 24 hours before drug addiction with an initial density of 3 Â 10 5 cells per mL. The cell supernatants were collected every three days and fresh cell culture medium contain corresponding test compounds were added. The experiment lasted nine days. The collected cell supernatants were used to analyse the levels of HBsAg, HBeAg and HBV DNA with their corresponding reagent kit. 
Statistical analysis
All data is expressed as mean AE SD. At least three independent experiments were performed, each in quintuplicate. The data is analysed using a one-way ANOVA. Statistically signicant effects were analysed, and the means are also compared using leastsignicant difference (LSD) test. Statistical signicance is determined at p < 0.05.
Results and discussion
Structural identication of new caffeoylquinic acids C NMR spectral data. The 1 H NMR and 13 C NMR spectrum (Table 1) showed a 4,5-disubstituted quinic acid methyl ester derivative of compound 1, which was conrmed according to a methoxyl group signal at d Fig. 3 . Ester hydrolysates of compound 1 produced the corresponding 4-Otrans-caffeoylquinic acid methyl ester (14) , which was identied by HPLC analysis. Therefore, we concluded that the trans-caffeoyl moiety was attached to C-4 of quinic acid methyl ester. Moreover, the other part of the ester hydrolysates 3-hydroxy-3-(3,4-dihydroxyphenyl)-propionic acid was measured to have an optical rotation value of [a]
22 D ¼ À4.6 , which was nearly equal to
Therefore, the C-7 00 conguration of compound 1 was identied as (Table 1) were consistent with that of 1 but with a difference of one more 24) indicated that the extra methoxyl group was attached to C-7 00 of the propionyl moiety (Fig. 3) . The 10 ppm down-eld shi of C-7 00 in the 13 were all 4-O-trans-caffeoylquinic acid methyl ester (14) , which were identied by HPLC analysis. The above results conrmed that the cis-caffeoyl group was linked to C-5 of compound 3 and C-3 of compound 4, respectively. The key HMBC and NOESY (H 4 H, blue) correlations of compounds 3 and 4 were shown in Fig. 3 . Therefore, the structures of compounds 3 and 4 were identied as 4-O-trans-caffeoyl-5-O-cis-caffeoyl quinic acid methyl ester and 3-O-cis-caffeoyl-4-O-trans-caffeoyl quinic acid methyl ester, respectively. The other compounds were identied as isovanillic acid (5) , compounds 11, 18 and 23 were tested for 50 mg ml
À1
, and the other compounds (1-5, 9-10, 12-16, 19-22) were tested for 100 mg ml
. Results are expressed as the mean AE SD (n ¼ 3). *p < 0.05 compared with the control group, **p < 0.01 compared with the control group, ***p < 0.001 compared with the control group. The HBeAg results of Fig. 5B showed that the replication rate of HBV was signicantly inhibited by compounds 3, 6-12, 17, 21, especially compounds 9-11, and their relative HBeAg levels as low as À70.76 AE 1.46, À71.20 AE 1.22, À46.01 AE 8.51%, respectively (p < 0.001). While HBV DNA reects the extents of HBV replication (Chen, et al., 2006) . As seen in Fig. 5C , most compounds exhibited remarkable decrease in the relative HBV DNA levels (p < 0.05). Compound 8 showed the most signicant inhibitory activity and its relative HBV DNA level was decreased by 83.11 AE 2.75%. However, several compounds (4, 11, 12, 16, (20) (21) (22) showed no signicantly inhibitory activity and some compounds (5, 18, 19, 23) showed strangely promoting activities. Unfortunately, we found that compound 23 promoted HBsAg and HBeAg secretion, and HBV DNA replication by 172.39 AE 2.59, 9.92 AE 6.91, and 55.40 AE 17.81%. Contrary to the study on anti-HBV activity of caffeoylquinic acids, there is presently no study that reports the HBV promoting activity of caffeoylquinic acids.
Structure-activity relationship analysis of these caffeoylquinic acids in anti-HBV activity suggested that the presence of caffeoyl groups in the molecule resulted in stronger anti-HBV activity. This conclusion resembles previous study on the structure-activity relationship of these compounds. 34 The two adjacent phenolic structure and a, b-conjugated unsaturated ester structure of caffeoyl groups increased benzene ring plane conjugation and resulted in the promotion of anti-HBV activity. For simple caffeic acid alone, compounds 6-8, 17 have signi-cantly anti-HBV activity (p < 0.001). However, compound 5 expressed inferior anti-HBV activity when compared to the other simple caffeic acid because its relative HBV DNA level (68.35 AE 15.26%) was signicantly increased compared to the control group (p < 0.001). This is because compound 5 (isovanillic acid, 3-hydroxy-4-methoxybenzoic acid) could not form a benzene ring plane conjugation without a two adjacent phenolic structure, so it exhibited poor activity. For monocaffeoylquinic acid, only compound 12 (3-O-caffeoylquinic acid) showed excellent anti-HBV activities (p < 0.001). Other isolated monocaffeoylquinic acids, namely 13 (1-O-caffeoylquinic acid methyl ester), 14 (4-O-caffeoylquinic acid methyl ester), 15 (3-O-caffeoylquinic acid methyl ester), and 18 (5-O-caffeoylquinic acid methyl ester), did not signicantly inhibited the secretion of HBsAg, HBeAg, and HBV DNA replication. These results suggest that carboxyl group in quinic acid was important for the accelerating effect on anti-HBV activities in monocaffeoylquinic acids. However, the caffeoylquinic acid ethyl ester derivatives (9) showed the best anti-HBV activity (p < 0.001). Perhaps further study on the structure-activity relationship of monocaffeoylquinic acids is worth discussing. For dicaffeoylquinic acids, compared to their structural analog (20) , new compounds 1 and 2 have only one caffeoyl group in the molecule, so they exhibited weaker activities than that of compound 20. Moreover, the anti-HBV activity of new compound 3 was far better than that of compound 20, which could be due to the cis-caffeoyl group in compound 3. The above results may suggest that the existence and conguration of the double bond moiety in caffeoyl group is important for anti-HBV activity. Tricaffeoylquinic acid, compound 23 (3,4,5-tri-O-caffeoylquinic acid methyl ester), had a steric hindrance because it contained three caffeoyl groups. The increased steric hindrance effect inhibited the anti-HBV activity of compound 23. Unfortunately, the relative HBsAg level (172.39 AE 2.59%) and HBV DNA level (55.40 AE 17.81%) of compound 23 was signicantly promoted (p < 0.001). Therefore, more studies are necessary to further understand the anti-HBV action mechanism of caffeoylquinic acid derivatives.
Conclusion
This study focuses on seeking anti-HBV agents from L. japonica ower buds, which are widely used in traditional Chinese medicine, healthy food, and cosmetics. Four new caffeoylquinic acids (1-4), ve simple caffeic acids (5) (6) (7) (8) 17) and fourteen known caffeoylquinic acids (9) (10) (11) (12) (13) (14) (15) (16) (18) (19) (20) (21) (22) (23) were isolated from L. japonica, of which caffeoylquinic acids exhibited potent HBV inhibitory activities. The results indicated that the HBV inhibitory activity of L. japonica ower buds may occur primarily because of the amount of caffeoylquinic acids present and this could serve as anti-HBV agents for functional food or medical use. Also, we found that compound 23 appeared to signicantly promote HBsAg and HBeAg secretion, and HBV DNA replication. Unlike the study on anti-HBV activity of caffeoylquinic acids, there is no current manuscript that reports caffeoylquinic acids can promote HBV activity.
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